A Case of 7-Hydroxymitragynine Use Disorder Treated With Buprenorphine
7-HMG is a widely available, largely unregulated, underrecognized substance with potency at the µ-opioid receptor that may increasingly concern clinicians and policymakers. Patients with 7-HMG use disorder may benefit from medication for opioid use disorder. More research is needed to characterize the effects of 7-HMG in humans and guide management.
Authors
- Gerardo González (ORCID: https://orcid.org/0000-0002-4285-742X)
- Zoe A. Karavolis (ORCID: https://orcid.org/0000-0003-2649-075X)
- Reuben Hendler
- Jungjin Kim
Institutions
- Harvard University (US)
- Hennepin County (US)
- McLean Hospital (US)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1097/adm.0000000000001685
- Primary Topic
- Alkaloids: synthesis and pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00